Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BHC stock hub

Bausch Health Companies Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BHCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.1B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

BHC

In the news

Latest news · BHC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E1.4

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC12.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BHC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000885590
Company name	Bausch Health Companies Inc.
Country	Canada
Country code	US
Cusip	071734107
Employees	20,300
Employees Change	-400%
Employees Change Percent	-1.93
Enterprise value	$21.6B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA0717341071
Last refreshed	2026-05-10
Market cap	$2.1B
Market cap category	Mid-Cap
Price	$5.75
Price currency	USD
Rev Per Employee	518,768.47x
Sector	Healthcare
Sic	2834
Symbol	BHC
Website	https://www.bauschhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-56.25%
EV Sales Forward	2x
EV/EBIT	8.96x
EV/EBITDA	5.99x
EV/FCF	21.05x
EV/Sales	2.06x
FCF yield	47.87%
Forward P/E	1.37x
P/S ratio	0.2x
PS Forward	0.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.94%
EBITDA Margin	34.32%
FCF margin	9.76%
Gross margin	71.04%
Gross Profit	$7.5B
Gross Profit Growth	8.61%
Gross Profit Growth Q	14.63%
Gross Profit Growth3 Y	9.14%
Gross Profit Growth5 Y	5.45%
Net Income	$-1.2B
Net Income Growth Years	2%
Pretax Margin	-8.93%
Profit Margin	-11.47%
Profit Per Employee	$-59,507
Profitable Years	1
ROA	5.93
Roa5y	4.05
ROCE	12.1
ROIC	12.53
Roic5y	4.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-15.2%
Cagr15y	-13.43%
Cagr1y	22.36%
Cagr20y	-5.55%
Cagr3y	-0.46%
Cagr5y	-27.18%
EPS Growth Years	2
FCF Growth	-16.22%
FCF Growth Q	26.04%
FCF Growth5 Y	0.61%
OCF Growth	-11.15%
OCF Growth Q	9.01%
OCF Growth10 Y	-4.81%
OCF Growth5 Y	1.88%
Revenue Growth	8.22x
Revenue Growth Q	11.73x
Revenue Growth Quarters	13x
Revenue Growth Years	3x
Revenue Growth3 Y	8.92x
Revenue Growth5 Y	5.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.41
Assets	$24.5B
Cash	$1.3B
Current Assets	$6B
Current Liabilities	$4.5B
Debt	$20.8B
Debt EBITDA	$5.59
Debt FCF	$20.23
Equity	$-1.1B
Interest Coverage	1.44
Liabilities	$25.6B
Long Term Assets	$18.5B
Long Term Liabilities	$21.1B
Net Cash	$-19.5B
Net Cash By Market Cap	$-908
Net Debt EBITDA	$5.39
Net Debt FCF	$18.96
Tangible Book Value	$-16.3B
Tangible Book Value Per Share	$-43.57
WACC	6.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.32
Inventory Turnover	1.9
Net Working Capital	$1B
Quick ratio	0.77
Working Capital	$1.4B
Working Capital Turnover	$7.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.81%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-80.76%
1Y total return	22.34%
200-day SMA	6.35
3Y total return	-1.37%
50-day SMA	5.47
50-day SMA vs 200-day SMA	50under200
5Y total return	-79.52%
All Time High	263.8
All Time High Change	-97.82%
All Time High Date	2015-08-06
All Time Low	0.33
All Time Low Change	1,626.73%
All Time Low Date	1994-04-21
ATR	0.23
Beta	0.42
Beta1y	1.89
Beta2y	0.84
Ch YTD	-17.27
High	5.8
High52	8.69
High52 Date	2025-08-15
High52ch	-33.79%
Low	5.64
Low52	4.41
Low52 Date	2025-05-23
Low52ch	30.39%
Ma50ch	5.22%
Premarket Change Percent	0.17
Premarket Price	$5.74
Premarket Volume	451
Price vs 200-day SMA	-9.42%
RSI	55.97
RSI Monthly	43.77
RSI Weekly	46.91
Sharpe ratio	0.57x
Sortino ratio	1.06
Total Return	-0.81%
Tr YTD	-17.27
Tr15y	-88.5%
Tr1m	9.32%
Tr1w	1.77%
Tr3m	-2.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Hold
Earnings EPS Estimate	$0.72
Earnings EPS Estimate Growth	18.03
Earnings Revenue Estimate	2,408,000,000x
Earnings Revenue Estimate Growth	6.6x
Operating Income	$2.4B
Operating Income Growth	29.06
Operating Income Growth Q	75.42
Operating Income Growth3 Y	20.55
Operating Income Growth5 Y	11.04
Operating margin	22.94
Price target	$8
Price Target Change	$39.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	260,570,783%
Float Percent	69.77%
Net Borrowing	-574,000,000
Shares Insiders	10.6%
Shares Institutions	34.59%
Shares Out	373,475,644
Shares Qo Q	-0.14%
Shares Yo Y	0.81%
Short Float	2.41%
Short Ratio	4.73
Short Shares	1.68

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$803M
Average Volume	1,702,763x
Bv Per Share	-5.51
CAPEX	$-391M
Ch10y	-80.76
Ch15y	-88.5
Ch1m	9.32
Ch1w	1.77
Ch1y	22.34
Ch20y	-78.03
Ch3m	-2.21
Ch3y	-1.37
Ch5y	-79.52
Ch6m	-13.53
Change	0.35%
Change From Open	0.88
Close	5.73
Days Gap	-0.52
Depreciation Amortization	1,198,000,000
Dollar Volume	7,191,208.8
Earnings Date	2026-04-29
Earnings Time	amc
EBIT	$2.4B
EBITDA	$3.6B
EPS	$-3.25
F Score	6
FCF	$1B
FCF EV Yield	4.75x
FCF Per Share	$2.75
Financing CF	-696,000,000
Fiscal Year End	December
Goodwill	9,807,000,000
Income Tax	$285M
Investing CF	-604,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2000-10-05
Last Split Type	Forward
Last10k Filing Date	2026-02-19
Ma150	6.16
Ma150ch	-6.72%
Ma20	5.69
Ma20ch	1%
Net CF	155,000,000
Open	5.7
Optionable	Yes
P FCF Ratio	2.09
P OCF Ratio	1.51
Position In Range	68.75
Post Close	5.75
Postmarket Change Percent	-0.87
Postmarket Price	$5.7
Ppne	2,095,000,000
Pre Close	5.73
Price Date	2026-05-08
Price EBITDA	$0.59
Relative Volume	0.73x
Revenue	10,531,000,000x
SBC By Revenue	2.14x
Share Based Comp	225,000,000
Tax By Revenue	2.71x
Tr20y	-68.11%
Tr6m	-13.53%
Volume	1,250,645
Z Score	0.25

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BHC pay a dividend?

Capital-return profile for this ticker.

Performance

BHC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BHC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+34.6%

Float: +69.8% of shares outstanding

Insider ownership

+10.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BHC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.0

Neutral momentum band

Price vs 200-day MA

-9.4%

50/200-day relationship not available

Beta (5Y)

0.42

Less volatile than the market

Sharpe ratio

0.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BHC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BHC stock rating?

Bausch Health Companies Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BHC analysis?

The full report lives at /stocks/BHC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BHC?

The latest report frames BHC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BHC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.